Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).
No Canadian shortage report is currently matched to this DIN.
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02461870 | APO-ERLOTINIB | APOTEX INC | Tablet | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 100 MG | Marketed |
| 02461862 | APO-ERLOTINIB | APOTEX INC | Tablet | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 25 MG | Marketed |
| 02454394 | PMS-ERLOTINIB | PHARMASCIENCE INC | Tablet | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 150 MG | Marketed |
| 02377691 | TEVA-ERLOTINIB | TEVA CANADA LIMITED | Tablet | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 25 MG | Marketed |
| 02377705 | TEVA-ERLOTINIB | TEVA CANADA LIMITED | Tablet | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 100 MG | Marketed |
| 02377713 | TEVA-ERLOTINIB | TEVA CANADA LIMITED | Tablet | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 150 MG | Marketed |
| 02483912 | NAT-ERLOTINIB | NATCO PHARMA (CANADA) INC | Tablet | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 25 MG | Dormant |
| 02483920 | NAT-ERLOTINIB | NATCO PHARMA (CANADA) INC | Tablet | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 100 MG | Dormant |
| 02483939 | NAT-ERLOTINIB | NATCO PHARMA (CANADA) INC | Tablet | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 150 MG | Dormant |
| 02454386 | PMS-ERLOTINIB | PHARMASCIENCE INC | Tablet | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 100 MG | Dormant |
| 02269007 | TARCEVA | HOFFMANN-LA ROCHE LIMITED | Tablet | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 25 MG | Cancelled Post Market |
| 02269023 | TARCEVA | HOFFMANN-LA ROCHE LIMITED | Tablet | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 150 MG | Cancelled Post Market |
| 02269015 | TARCEVA | HOFFMANN-LA ROCHE LIMITED | Tablet | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 100 MG | Cancelled Post Market |